0000950170-23-043038.txt : 20230816
0000950170-23-043038.hdr.sgml : 20230816
20230816165045
ACCESSION NUMBER: 0000950170-23-043038
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230814
FILED AS OF DATE: 20230816
DATE AS OF CHANGE: 20230816
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bullock John
CENTRAL INDEX KEY: 0001595347
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-13323
FILM NUMBER: 231178795
MAIL ADDRESS:
STREET 1: 251 O'CONNOR RIDGE BLVD.
STREET 2: SUITE 300
CITY: IRVING
STATE: TX
ZIP: 75038
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DARLING INGREDIENTS INC.
CENTRAL INDEX KEY: 0000916540
STANDARD INDUSTRIAL CLASSIFICATION: FATS & OILS [2070]
IRS NUMBER: 362495346
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1230
BUSINESS ADDRESS:
STREET 1: 5601 N MACARTHUR BLVD
CITY: IRVING
STATE: TX
ZIP: 75038
BUSINESS PHONE: 9727170300
MAIL ADDRESS:
STREET 1: 5601 N MACARTHUR BLVD
CITY: IRVING
STATE: TX
ZIP: 75038
FORMER COMPANY:
FORMER CONFORMED NAME: DARLING INTERNATIONAL INC
DATE OF NAME CHANGE: 19931223
4
1
ownership.xml
4
X0508
4
2023-08-14
0000916540
DARLING INGREDIENTS INC.
DAR
0001595347
Bullock John
5601 N. MACARTHUR BLVD
IRVING
TX
75038
true
EVP Chief Strategy Officer
false
Common Stock
2023-08-14
4
S
false
43720
65
D
57469
D
Common Stock
2023-08-16
5
G
false
5000
0
D
52469
D
Common Stock
2023-08-14
4
M
false
34427
18.82
A
86896
D
Common Stock
2023-08-14
4
F
false
19547
65.48
D
67349
D
Common Stock
2023-08-14
4
S
false
14880
65.48
D
52469
D
Options (right to buy)
18.82
2023-08-14
4
M
false
34427
0
D
2021-01-29
2028-01-29
Common Stock
34427
0
D
On 08/16/2023, the reporting person donated 5,000 shares of directly owned shares of common stock to a donor-advised fund, which will use the gifted shares for charitable purposes.
This transaction was executed in multiple trades at prices ranging from $65.44 to $65.57; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
Options granted pursuant to 2017 Omnibus Incentive Plan to purchase 11,476 shares became exercisable on 01/29/2019 and 01/29/2020 and 11,475 shares became exercisable on 01/29/2021.
/s/ John Bullock
2023-08-16